TAZ inhibits osteoclastogenesis by attenuating TAK1/NF-κB signaling
Open Access
- 12 July 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Bone Research
- Vol. 9 (1), 1-10
- https://doi.org/10.1038/s41413-021-00151-3
Abstract
Osteoporosis is an osteolytic disorder commonly associated with excessive osteoclast formation. Transcriptional coactivator with PDZ-binding motif (TAZ) is a key downstream effector of the Hippo signaling pathway; it was suggested to be involved in the regulation of bone homeostasis. However, the exact role of TAZ in osteoclasts has not yet been established. In this study, we demonstrated that global knockout and osteoclast-specific knockout of TAZ led to a low-bone mass phenotype due to elevated osteoclast formation, which was further evidenced by in vitro osteoclast formation assays. Moreover, the overexpression of TAZ inhibited RANKL-induced osteoclast formation, whereas silencing of TAZ reduced it. Mechanistically, TAZ bound to TGF-activated kinase 1 (TAK1) and reciprocally inhibited NF-κB signaling, suppressing osteoclast differentiation. Collectively, our findings highlight an essential role of TAZ in the regulation of osteoclastogenesis in osteoporosis and its underlying mechanism.Keywords
This publication has 43 references indexed in Scilit:
- Modulating TAK1 Expression Inhibits YAP and TAZ Oncogenic Functions in Pancreatic CancerMolecular Cancer Therapeutics, 2020
- Mechanical regulation of bone homeostasis through p130Cas-mediated alleviation of NF-κB activityScience Advances, 2019
- YAP1 is essential for osteoclastogenesis through a TEADs-dependent mechanismBone, 2018
- Hippo Pathway in Organ Size Control, Tissue Homeostasis, and CancerCell, 2015
- Role of TAZ as Mediator of Wnt SignalingCell, 2012
- Glomerulocystic kidney disease in mice with a targeted inactivation of Wwtr1Proceedings of the National Academy of Sciences of the United States of America, 2007
- Transcriptional activity of Pax3 is co-activated by TAZBiochemical and Biophysical Research Communications, 2006
- A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt–Oram syndromeProceedings of the National Academy of Sciences of the United States of America, 2005
- TAZ, a Transcriptional Modulator of Mesenchymal Stem Cell DifferentiationScience, 2005
- TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteinsThe EMBO Journal, 2000